Utah Medical Products, Inc.
UTMD
$52.34
-$0.53-1.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 9.16M | 10.01M | 10.40M | 11.34M | 12.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 9.16M | 10.01M | 10.40M | 11.34M | 12.33M |
| Cost of Revenue | 3.84M | 4.20M | 4.15M | 4.57M | 5.24M |
| Gross Profit | 5.32M | 5.80M | 6.25M | 6.77M | 7.10M |
| SG&A Expenses | 1.94M | 1.87M | 1.93M | 1.87M | 2.35M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.89M | 6.25M | 6.33M | 6.71M | 7.73M |
| Operating Income | 3.27M | 3.76M | 4.07M | 4.63M | 4.60M |
| Income Before Tax | 3.61M | 4.18M | 4.21M | 4.80M | 5.02M |
| Income Tax Expenses | 712.00K | 616.00K | 758.00K | 842.00K | 731.00K |
| Earnings from Continuing Operations | 2.90M | 3.56M | 3.45M | 3.96M | 4.29M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 2.90M | 3.56M | 3.45M | 3.96M | 4.29M |
| EBIT | 3.27M | 3.76M | 4.07M | 4.63M | 4.60M |
| EBITDA | 3.98M | 4.48M | 4.75M | 5.30M | 5.63M |
| EPS Basic | 0.86 | 1.02 | 0.98 | 1.09 | 1.18 |
| Normalized Basic EPS | 0.73 | 0.83 | 0.86 | 0.96 | 0.98 |
| EPS Diluted | 0.86 | 1.02 | 0.98 | 1.09 | 1.18 |
| Normalized Diluted EPS | 0.73 | 0.83 | 0.86 | 0.96 | 0.98 |
| Average Basic Shares Outstanding | 3.39M | 3.48M | 3.53M | 3.62M | 3.63M |
| Average Diluted Shares Outstanding | 3.39M | 3.48M | 3.53M | 3.62M | 3.63M |
| Dividend Per Share | 0.31 | 0.30 | 0.30 | 0.30 | 0.30 |
| Payout Ratio | 35.77% | 29.53% | 31.31% | 27.53% | 24.99% |